Cart
sales@molnova.com
Amosulalol
CAS No. 85320-68-9
Amosulalol( —— )
Catalog No. M27959 CAS No. 85320-68-9
Amosulalol is an Adrenergic Agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 454 | In Stock |
|
| 2MG | 278 | In Stock |
|
| 5MG | 426 | In Stock |
|
| 10MG | 625 | In Stock |
|
| 25MG | 938 | In Stock |
|
| 50MG | 1283 | In Stock |
|
| 100MG | 1758 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAmosulalol
-
NoteResearch use only, not for human use.
-
Brief DescriptionAmosulalol is an Adrenergic Agent.
-
DescriptionAmosulalol is an Adrenergic Agent.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorFAAH
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number85320-68-9
-
Formula Weight380.46
-
Molecular FormulaC18H24N2O5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1ccccc1OCCNCC(O)c1ccc(C)c(c1)S(N)(=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wang Xueqing, et al. Synthesis and Evaluation of Benzothiazole-Based Analogues as Novel, Potent, and Selective Fatty Acid Amide Hydrolase Inhibitors. Journal of Medicinal Chemistry (2009), 52(1), 170-180.
molnova catalog
related products
-
Pomalidomide 4-PEG3-...
Pomalidomide 4'-PEG3-azide is a chemically synthesized E3 ligase ligand-linker conjugate that incorporates the cereblon ligand derived from Pomalidomide, along with a linker.
-
KRAS G12D inhibitor ...
KRAS G12D inhibitor 14 is a potent compound that binds the KRAS G12D protein (Kd: 33 nM) and selectively inhibits the active form KRAS G12D-GTP, but not KRAS G13D.
-
[Ala1,?3,?11,?15]?-?...
[Ala1,3,11,15]-Endothelin (TFA) is a highly selective for endothelin A (ETA) and endothelin B (ETB) receptor.[Ala1,?3,?11,?15]?-?Endothelin is a selective ETB endothelin receptor agonist (IC50 values are 0.33 and 2200 nM for displacing [125I]-ET-1 from ETB and ETA receptors respectively).
